INTRODUCTIONAcetyl hexapeptide-8, marketed as Argireline® (Lipotec, Barcelona, Spain), is a six-amino-acid biomimetic of botulinum toxin promoted as a wrinkle-reducing compound. It entered the market in 2001 and has grown in…
Read More
INTRODUCTIONHidradenitis Suppurativa (HS) is a notoriously difficult-to-treat inflammatory skin condition characterized by the presence of deep, painful nodules, abscesses, tracts, and fibrotic scars, often occurring in intertriginous and apocrine gland-rich…
Read More
INTRODUCTIONGlucagon-like peptide-1 (GLP-1) agonists are used to treat type 2 diabetes mellitus (T2DM) and have recently gained approval and popularity for treating obesity and weight loss. With the recent increase…
Read More
INTRODUCTION Socioeconomic development is associated with cancer's prevalence and distribution. According to the GLOBOCAN Estimates of Incidence and Mortality Worldwide, the estimated incidence rate (ASR) for males and females in…
Read More
INTRODUCTIONAtopic dermatitis (AD) is a common, chronic inflammatory skin disease for which cutaneous dysbiosis is a core component of disease pathophysiology.1,2 AD-associated dysbiotic changes in the skin microbiome composition include…
Read More
INTRODUCTIONImmune checkpoints are inhibitory pathways within the immune system that maintain self-tolerance and regulate the duration and strength of immune responses.1 Tumors can exploit this mechanism to evade immune surveillance…
Read More
INTRODUCTION Acne is the most common cutaneous disease worldwide and the most frequent disorder to present to the dermatology practice. Although efficacious treatments exist, clinicians continue to search for better…
Read More
INTRODUCTIONIn 2024, an estimated >200,000 new cases of cancer will be diagnosed in Nordic Europeans. Apart from non-melanoma skin cancer, the 4 most commonly diagnosed cancers are prostate, breast, lung,…
Read More
In this issue NECOM 5: Algorithm for the Treatment and Supportive Management of Targeted Therapy-Related Cutaneous Adverse EventsIn 2024, an estimated >200,000 new cases of cancer will be diagnosed in Nordic…
Read More
INTRODUCTIONSeborrheic dermatitis (SD) and dandruff are of a continuous spectrum of the same disease that affects the seborrheic areas of the body, with dandruff being milder and specifically localized to…
Read More
In this issue: A Clinical Evaluation of Scalp Barrier Function, Ceramide Levels, and Microbiome in Diverse Dandruff Patients Seborrheic dermatitis (SD) and dandruff are of a continuous spectrum of the…
Read More
Dear Editor, Seborrheic dermatitis (SD) is a persistent inflammatory skin condition, marked by red scaly patches primarily on the scalp, nasal area, and chest, often with itching and flaking.1 Despite…
Read More
